project id: TCGA-SKCM; case submitter id: TCGA-EE-A3JB; source center: 23; state: released; a260 a280 ratio: 1.86; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 9.0; age at index: 60; days to birth: -22150; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1932; age at diagnosis: 22150; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 3rd; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 6138.0; icd 10 code: C49.1; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of upper limb and shoulder; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 1992; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 7131; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-EE-A3JB-06A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0;